Mankind Pharma Limited (NSE: MANKIND)
India
· Delayed Price · Currency is INR 2,581.80
+100.20 (4.04%)
Feb 3, 2025, 3:30 PM IST
Mankind Pharma Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
| Revenue | 116,410 | 103,348 | 87,494 | 77,816 | 62,144 | 58,719 | Upgrade
|
| Revenue Growth (YoY) | 17.04% | 18.12% | 12.44% | 25.22% | 5.83% | 17.91% | Upgrade
|
| Cost of Revenue | 34,710 | 33,207 | 30,031 | 24,879 | 18,471 | 19,219 | Upgrade
|
| Gross Profit | 81,701 | 70,141 | 57,463 | 52,937 | 43,673 | 39,500 | Upgrade
|
| Selling, General & Admin | 31,985 | 29,018 | 23,126 | 20,934 | 18,195 | 16,082 | Upgrade
|
| Other Operating Expenses | 20,038 | 15,622 | 15,195 | 12,014 | 8,386 | 7,722 | Upgrade
|
| Operating Expenses | 57,127 | 48,622 | 41,580 | 34,614 | 27,770 | 24,794 | Upgrade
|
| Operating Income | 24,573 | 21,518 | 15,883 | 18,322 | 15,903 | 14,706 | Upgrade
|
| Interest Expense | -2,434 | -286 | -402.74 | -557.8 | -193.03 | -215.51 | Upgrade
|
| Interest & Investment Income | 400.53 | 400.53 | 127.67 | 129.25 | 387.27 | 171.78 | Upgrade
|
| Earnings From Equity Investments | 123.34 | 152.14 | 124.24 | 144.48 | 116.77 | 115.35 | Upgrade
|
| Currency Exchange Gain (Loss) | 86.36 | 86.36 | 104.06 | 88.45 | 5.02 | -10.25 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,865 | 878.52 | 536.42 | 486 | 51.17 | 49.44 | Upgrade
|
| EBT Excluding Unusual Items | 24,615 | 22,750 | 16,372 | 18,613 | 16,270 | 14,816 | Upgrade
|
| Impairment of Goodwill | - | - | -38.52 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,295 | 1,295 | 374.31 | 1,129 | 628.65 | -224.41 | Upgrade
|
| Gain (Loss) on Sale of Assets | 4.8 | 4.8 | 16.65 | -37.41 | -30.45 | 109.54 | Upgrade
|
| Asset Writedown | -91.63 | -91.63 | -97.08 | -57.63 | -38.88 | -207.66 | Upgrade
|
| Other Unusual Items | 24.79 | 24.79 | 41.53 | 85.27 | 77.21 | -123.14 | Upgrade
|
| Pretax Income | 25,858 | 23,994 | 16,712 | 19,746 | 16,916 | 14,377 | Upgrade
|
| Income Tax Expense | 5,228 | 4,576 | 3,616 | 5,216 | 3,986 | 3,816 | Upgrade
|
| Earnings From Continuing Operations | 20,631 | 19,418 | 13,097 | 14,530 | 12,930 | 10,561 | Upgrade
|
| Minority Interest in Earnings | -216.35 | -288.75 | -278.17 | -194.81 | -276.07 | -257.23 | Upgrade
|
| Net Income | 20,414 | 19,129 | 12,819 | 14,335 | 12,654 | 10,304 | Upgrade
|
| Net Income to Common | 20,414 | 19,129 | 12,819 | 14,335 | 12,654 | 10,304 | Upgrade
|
| Net Income Growth | 18.20% | 49.23% | -10.58% | 13.28% | 22.81% | 78.11% | Upgrade
|
| Shares Outstanding (Basic) | 401 | 401 | 401 | 401 | 401 | 401 | Upgrade
|
| Shares Outstanding (Diluted) | 402 | 401 | 401 | 401 | 401 | 401 | Upgrade
|
| Shares Change (YoY) | 0.20% | 0.14% | 0.00% | - | - | - | Upgrade
|
| EPS (Basic) | 50.90 | 47.75 | 32.00 | 35.78 | 31.59 | 25.72 | Upgrade
|
| EPS (Diluted) | 50.81 | 47.68 | 32.00 | 35.78 | 31.59 | 25.72 | Upgrade
|
| EPS Growth | 17.96% | 49.00% | -10.57% | 13.27% | 22.82% | 78.12% | Upgrade
|
| Free Cash Flow | - | 18,371 | 10,243 | 4,549 | 8,318 | 8,442 | Upgrade
|
| Free Cash Flow Per Share | - | 45.79 | 25.57 | 11.36 | 20.77 | 21.07 | Upgrade
|
| Dividend Per Share | - | - | - | - | - | 3.100 | Upgrade
|
| Dividend Growth | - | - | - | - | - | -30.34% | Upgrade
|
| Gross Margin | 70.18% | 67.87% | 65.68% | 68.03% | 70.28% | 67.27% | Upgrade
|
| Operating Margin | 21.11% | 20.82% | 18.15% | 23.55% | 25.59% | 25.04% | Upgrade
|
| Profit Margin | 17.54% | 18.51% | 14.65% | 18.42% | 20.36% | 17.55% | Upgrade
|
| Free Cash Flow Margin | - | 17.78% | 11.71% | 5.85% | 13.39% | 14.38% | Upgrade
|
| EBITDA | 28,931 | 25,366 | 19,051 | 19,910 | 17,038 | 15,654 | Upgrade
|
| EBITDA Margin | 24.85% | 24.54% | 21.77% | 25.59% | 27.42% | 26.66% | Upgrade
|
| D&A For EBITDA | 4,357 | 3,848 | 3,168 | 1,588 | 1,135 | 948.47 | Upgrade
|
| EBIT | 24,573 | 21,518 | 15,883 | 18,322 | 15,903 | 14,706 | Upgrade
|
| EBIT Margin | 21.11% | 20.82% | 18.15% | 23.55% | 25.59% | 25.04% | Upgrade
|
| Effective Tax Rate | 20.22% | 19.07% | 21.63% | 26.42% | 23.56% | 26.54% | Upgrade
|
| Revenue as Reported | 120,205 | 106,156 | 88,780 | 79,776 | 63,854 | 59,757 | Upgrade
|
| Advertising Expenses | - | 6,039 | 3,737 | 4,516 | 3,857 | 2,553 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.